CEPHEID NORWAY AS
Operating
Produsere, forske, utvikle, konsultere, levere, handle inkludert
import og eksport og på annen måte håndtere alle slags medisinske
apparater, diagnosesystemer, måleinstrumenter og systemer,
analyseinnretninger og -systemer, deteksjonsinnretninger og systemer,
tester, re-agenter, programvare, deler og tilbehør for kliniske og
biovitenskapelige markeder.
Produsere, forske, utvikle, konsultere, levere, handle inkludert
import og eksport og på annen måte håndtere alle slags medisinske
apparater, diagnosesystemer, måleinstrumenter og -systemer,
analyseinnretninger og -systemer, deteksjonsinnretninger og -systemer,
tester, re-agenter, programvare, deler og tilbehør for kliniske og
biovitenskapelige markeder.
Organization
- Chairman of the board
- JA
- Years since formation
- 5 years
- since May 4, 2021
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 30,000
- 1 share class
- Total number of shareholders
- 1
- person
Financials
- Total operating income 2025
- 42,729,209
- NOK
- Annual total result 2025
- 2,014,487
- NOK
- Total equity 2025
- 23,891,685
- NOK
Last update: Jul 18, 2026
Management
Board
| Name | Role | Shares |
|---|---|---|
JA | Chairman | - |
MN 1975 | Board Member | - |
AJ 1981 | Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Auditor | - | |
| Accountant | - |
Last update: Apr 25, 2026
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 30,000 | 100 % |
Last update: Sep 25, 2026
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 42,729,209 | 55,499,005 | 73,973,847 | 103,509,243 | 30,967,751 |
Annual Total Result | 2,014,487 | 2,977,975 | 3,652,937 | 5,349,260 | 1,267,026 |
Total assets | 44,036,872 | 50,694,221 | 73,057,197 | 47,555,610 | 45,810,110 |
Total liabilities | 20,145,187 | 28,817,023 | 54,157,973 | 32,309,323 | 35,913,084 |
Total equity | 23,891,685 | 21,877,199 | 18,899,224 | 15,246,287 | 9,897,026 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 42,729,209 | 55,499,005 | 73,973,847 | 103,509,243 | 30,967,751 |
Total operating costs | 40,693,976 | 49,286,509 | 71,194,145 | 95,601,290 | 30,128,386 |
Operating result | 2,035,234 | 6,212,497 | 2,779,703 | 7,907,953 | 839,365 |
Financial income/costs | 547,498 | -2,397,458 | 1,907,455 | -1,049,287 | 785,027 |
Profit before tax | 2,582,732 | 3,815,039 | 4,687,158 | 6,858,666 | 1,624,392 |
Total tax & extraordinary income/cost | 568,245 | 837,064 | 1,034,221 | 1,509,406 | 357,366 |
Annual Total Result | 2,014,487 | 2,977,975 | 3,652,937 | 5,349,260 | 1,267,026 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total fixed assets | 57,135 | 65,332 | 80,026 | 105,421 | 0 |
Total current assets | 43,979,737 | 50,628,890 | 72,977,171 | 47,450,189 | 45,810,110 |
Total assets | 44,036,872 | 50,694,221 | 73,057,197 | 47,555,610 | 45,810,110 |
Short term debt | 20,145,187 | 28,817,023 | 54,157,973 | 32,309,323 | 35,913,084 |
Long term debt | 0 | 0 | 0 | 0 | 0 |
Total liabilities | 20,145,187 | 28,817,023 | 54,157,973 | 32,309,323 | 35,913,084 |
Contributed capital | 8,630,000 | 8,630,000 | 8,630,000 | 8,630,000 | 8,630,000 |
Retained earnings | 15,261,685 | 13,247,199 | 10,269,224 | 6,616,287 | 1,267,026 |
Total equity | 23,891,685 | 21,877,199 | 18,899,224 | 15,246,287 | 9,897,026 |
Total equity and liabilities | 44,036,872 | 50,694,221 | 73,057,197 | 47,555,610 | 45,810,110 |
Classification
21st company classification
BETA
Industrial large enterprise
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification